NDAC Input Sought On Sunscreen Ingredient Data Necessary For Approval
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA’s Nonprescription Drugs Advisory Committee will meet Sept. 4-5 to discuss the scope and safety of testing necessary for OTC sunscreen ingredients. The announcement comes after FDA earlier this year rejected time and extent applications to add new sunscreen actives to the OTC monograph.